Literature DB >> 20666683

Intraoperative intravitreal injection of triamcinolone acetonide for cataract extraction in patients with uveitis.

Ayman A Alkawas1, Alaa M Hamdy, Ezzat A Shahien.   

Abstract

PURPOSE: To evaluate the efficacy of intravitreal triamcinolone injection in controlling postoperative inflammation after cataract extraction in patients with uveitis.
METHODS: This retrospective study included 30 eyes with uveitis that had phacoemulsification or extracapsular cataract extraction with intraocular lens implantation. Intravitreal triamcinolone acetonide (4 mg) was injected at the end of surgery. No systemic steroids were given after surgery.
RESULTS: Visual acuity improvement of 2 lines or more occurred in 26 eyes (86.7%). Six eyes (20%) had a best-corrected visual acuity of 6/60 or better before surgery, which increased to 22 eyes (73.3%) after surgery. Five eyes (16.7%) had a visual acuity of 6/12 or better after surgery. Intravitreal triamcinolone injection controlled the postoperative inflammation in all eyes for at least 3 months following surgery.
CONCLUSION: Intravitreal triamcinolone injection was effective in controlling postoperative inflammation after cataract extraction in patients with uveitis sparing the use of systemic steroids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20666683     DOI: 10.3109/09273948.2010.486098

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

1.  Cataract surgery in patients with history of uveitis.

Authors:  Ujwala Baheti; Sana S Siddique; C Stephen Foster
Journal:  Saudi J Ophthalmol       Date:  2012-01

2.  Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract.

Authors:  Yan Ren; Shufang Du; Dongping Zheng; Yanyun Shi; Luping Pan; Hua Yan
Journal:  BMC Ophthalmol       Date:  2021-06-04       Impact factor: 2.209

3.  Efficacy of subtenon 20-mg triamcinolone injection versus 0.1% dexamethasone eye drops for controlling inflammation after phacoemulsification: a randomized controlled trial.

Authors:  Pitipol Choopong; Nuttacha Taetrongchit; Sutasinee Boonsopon; Atchariya Nimkarn; Kanyapak Srisukkosalin; Pratuangsri Chonpimai; Waree Nujoi; Krissana Maneephagaphun; Noppakhun Panyayingyong; Nattaporn Tesavibul
Journal:  Sci Rep       Date:  2022-10-01       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.